Johnson & Johnson MedTech launches electrosurgical generator that will work with Ottava surgical robot (2025)

(NYSE: JNJ) announced today that it launched its FDA-cleared Dualto energy system.

Dualto is a surgical solution that combines multiple energy modalities into an integrated platform for use across open and minimally invasive surgery. J&J designed it to work with its Polyphonic Fleet software application for device management. Additionally, the company plans for the future use of Dualto with its highly anticipated Ottava surgical robot.

J&J plans to showcase Dualto at the Association of periOperative Registered Nurses (AORN) Global Surgical Conference & Expo in Boston next month.

The medtech giant designed Dualto to deliver the choice of powering monopolar, bipolar, ultrasonic, and advanced bipolar instruments. Those include the Harmonic and Enseal devices, all powered through a single, consolidated system. Its modular design and flexible architecture allows for nearly half (46%) the footprint of separate generators.

[For more on the wide world of surgical robotics, download our free special report on the space.]

Johnson & Johnson MedTech says Dualto is the first and only surgical energy system to be made available in double configuration. This enables two surgeons to work in a complex procedure and activate simultaneous energy from one unit.

“The Dualto energy system represents a significant advancement in human-centric design, delivering a fully connected solution that simplifies surgical energy and enhances efficiencies in the OR,” said Hani Abouhalka, company group chair, Surgery, Johnson & JohnsonMedTech. “Johnson & Johnson MedTech has been a trusted partner in surgery for over a century, and we are leveraging clinical insights to tailor the design of our technologies to meet the needs of surgeons and clinical teams. Dualto supports a more flexible and digitally connected OR ecosystem for the future of surgical care.”

More about the Johnson & Johnson MedTech Dualto system

Dualto leverages proprietary adaptive tissue technology to enhance the performance of the Harmonic and Enseal devices. Adaptive tissue technology responds intelligently to changing tissue conditions and regulates energy delivery. It delivers improved temperature management and provides tone changes and user signals for more precise energy delivery.

The company says its streamlined OR setup with Dualto could help minimize stress levels for surgeons and clinical teams. Dualto prioritizes usability with an instinctive touchscreen interface with clear visual and auditory cues. It offers real-time feedback and streamlined workflows with faster setup and adjustments through custom settings.

Johnson & Johnson MedTech’s Polyphonic Fleet software application helps hospitals oversee capital equipment. The application can inform the status of Dualto for software upgrades and routine maintenance needs.

The company plans to make Dualto and Polyphonic Fleet available to select hospital sites in select markets “soon.” Ottava remains under development and investigational.

“Johnson & Johnson MedTech’s Polyphonic ecosystem will enable new experiences across our portfolio of medical devices, robotics, and software solutions,” said Shan Jegatheeswaran, VP, Digital,Johnson & Johnson MedTech. “Dualto combines advanced energy technology with Polyphonic Fleet’s ecosystem to provide remote support. We are excited to empower healthcare teams with capabilities for more connected OR devices.”